BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 55 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,115 | -89.7% | 30,555 | +5.6% | 0.00% | – |
| Q2 2023 | $59,612 | -53.5% | 28,938 | -25.5% | 0.00% | – |
| Q1 2023 | $128,139 | +224.3% | 38,830 | +61.1% | 0.00% | – |
| Q4 2022 | $39,518 | -75.6% | 24,096 | -34.0% | 0.00% | – |
| Q3 2022 | $162,000 | +43.4% | 36,517 | -10.9% | 0.00% | – |
| Q2 2022 | $113,000 | -31.1% | 40,982 | -16.5% | 0.00% | – |
| Q1 2022 | $164,000 | -20.8% | 49,106 | -4.9% | 0.00% | – |
| Q4 2021 | $207,000 | +19.0% | 51,660 | -1.6% | 0.00% | – |
| Q3 2021 | $174,000 | -15.1% | 52,514 | -2.2% | 0.00% | – |
| Q2 2021 | $205,000 | +41.4% | 53,685 | +42.3% | 0.00% | – |
| Q1 2021 | $145,000 | -85.0% | 37,721 | -82.3% | 0.00% | – |
| Q4 2020 | $964,000 | -47.1% | 213,002 | +97.9% | 0.00% | – |
| Q3 2020 | $1,821,000 | +92.9% | 107,652 | +27.8% | 0.00% | – |
| Q2 2020 | $944,000 | +686.7% | 84,239 | +226.1% | 0.00% | – |
| Q1 2020 | $120,000 | +46.3% | 25,832 | +34.1% | 0.00% | – |
| Q4 2019 | $82,000 | +15.5% | 19,265 | +5.8% | 0.00% | – |
| Q3 2019 | $71,000 | -13.4% | 18,211 | -12.3% | 0.00% | – |
| Q2 2019 | $82,000 | -5.7% | 20,764 | +3.8% | 0.00% | – |
| Q1 2019 | $87,000 | +148.6% | 19,995 | +104.1% | 0.00% | – |
| Q4 2018 | $35,000 | -5.4% | 9,795 | 0.0% | 0.00% | – |
| Q3 2018 | $37,000 | -82.1% | 9,795 | -81.5% | 0.00% | – |
| Q2 2018 | $207,000 | +33.5% | 53,077 | +7.9% | 0.00% | – |
| Q1 2018 | $155,000 | +384.4% | 49,200 | +500.0% | 0.00% | – |
| Q4 2017 | $32,000 | +28.0% | 8,200 | +36.7% | 0.00% | – |
| Q3 2017 | $25,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q2 2017 | $25,000 | -51.9% | 6,000 | -50.0% | 0.00% | – |
| Q1 2017 | $52,000 | +188.9% | 12,000 | +71.4% | 0.00% | – |
| Q4 2016 | $18,000 | +800.0% | 7,000 | +600.0% | 0.00% | – |
| Q3 2016 | $2,000 | – | 1,000 | +900.0% | 0.00% | – |
| Q3 2015 | $0 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABNER HERRMAN & BROCK LLC | 241,500 | $1,093,000 | 0.17% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 90,584 | $410,000 | 0.13% |
| EPIQ PARTNERS, LLC | 10,550 | $48,000 | 0.03% |
| Phoenix Holdings Ltd. | 173,683 | $799,000 | 0.02% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 5,500 | $25,000 | 0.02% |
| CFO4Life Group, LLC | 12,003 | $54,000 | 0.02% |
| HighPoint Advisor Group LLC | 15,733 | $115,000 | 0.01% |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | 357,761 | $1,619,000 | 0.01% |
| Virtu Financial LLC | 24,484 | $111,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 93,902 | $435,000 | 0.01% |